vs
Clearfield, Inc.（CLFD）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是Clearfield, Inc.的1.3倍（$44.6M vs $34.3M），Clearfield, Inc.净利率更高（-1.8% vs -90.4%，领先88.6%），帕可Bio同比增速更快（13.8% vs -3.2%），Clearfield, Inc.自由现金流更多（$-2.4M vs $-19.9M），过去两年帕可Bio的营收复合增速更高（7.3% vs -3.5%）
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市，是一家专注于光纤产品研发生产的企业，其产品主要应用于光纤通信网络建设领域，为通信基础设施部署提供相关硬件支撑。
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
CLFD vs PACB — 直观对比
营收规模更大
PACB
是对方的1.3倍
$34.3M
营收增速更快
PACB
高出17.0%
-3.2%
净利率更高
CLFD
高出88.6%
-90.4%
自由现金流更多
CLFD
多$17.5M
$-19.9M
两年增速更快
PACB
近两年复合增速
-3.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.3M | $44.6M |
| 净利润 | $-614.0K | $-40.4M |
| 毛利率 | 33.2% | 37.1% |
| 营业利润率 | -5.3% | -92.3% |
| 净利率 | -1.8% | -90.4% |
| 营收同比 | -3.2% | 13.8% |
| 净利润同比 | 67.8% | -1802.7% |
| 每股收益（稀释后） | $-0.04 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLFDPACB
| Q4 25 | $34.3M | $44.6M | ||
| Q3 25 | $23.4M | $38.4M | ||
| Q2 25 | $49.9M | $39.8M | ||
| Q1 25 | $47.2M | $37.2M | ||
| Q4 24 | $29.7M | $39.2M | ||
| Q3 24 | $5.6M | $40.0M | ||
| Q2 24 | $48.8M | $36.0M | ||
| Q1 24 | $36.9M | $38.8M |
净利润CLFDPACB
| Q4 25 | $-614.0K | $-40.4M | ||
| Q3 25 | $-9.1M | $-38.0M | ||
| Q2 25 | $1.6M | $-41.9M | ||
| Q1 25 | $1.3M | $-426.1M | ||
| Q4 24 | $-1.9M | $2.4M | ||
| Q3 24 | — | $-60.7M | ||
| Q2 24 | $-447.0K | $-173.3M | ||
| Q1 24 | $-5.9M | $-78.2M |
毛利率CLFDPACB
| Q4 25 | 33.2% | 37.1% | ||
| Q3 25 | 53.2% | 41.4% | ||
| Q2 25 | 30.5% | 36.9% | ||
| Q1 25 | 30.1% | -3.7% | ||
| Q4 24 | 29.2% | 25.6% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | 21.9% | 16.5% | ||
| Q1 24 | 7.7% | 29.1% |
营业利润率CLFDPACB
| Q4 25 | -5.3% | -92.3% | ||
| Q3 25 | 10.3% | -101.1% | ||
| Q2 25 | 3.0% | -112.8% | ||
| Q1 25 | 0.6% | -1154.5% | ||
| Q4 24 | -6.9% | -390.1% | ||
| Q3 24 | — | -160.3% | ||
| Q2 24 | -4.7% | -488.3% | ||
| Q1 24 | -26.4% | -209.6% |
净利率CLFDPACB
| Q4 25 | -1.8% | -90.4% | ||
| Q3 25 | -38.8% | -98.9% | ||
| Q2 25 | 3.2% | -105.4% | ||
| Q1 25 | 2.8% | -1146.8% | ||
| Q4 24 | -6.4% | 6.0% | ||
| Q3 24 | — | -151.9% | ||
| Q2 24 | -0.9% | -481.3% | ||
| Q1 24 | -16.0% | -201.4% |
每股收益（稀释后）CLFDPACB
| Q4 25 | $-0.04 | $-0.11 | ||
| Q3 25 | $-0.65 | $-0.13 | ||
| Q2 25 | $0.11 | $-0.14 | ||
| Q1 25 | $0.09 | $-1.44 | ||
| Q4 24 | $-0.13 | $-0.44 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | $-0.04 | $-0.64 | ||
| Q1 24 | $-0.40 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $96.4M | $279.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $249.7M | $5.3M |
| 总资产 | $268.1M | $784.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLFDPACB
| Q4 25 | $96.4M | $279.5M | ||
| Q3 25 | $106.0M | $298.7M | ||
| Q2 25 | $117.2M | $314.7M | ||
| Q1 25 | $112.0M | $343.1M | ||
| Q4 24 | $113.0M | $389.9M | ||
| Q3 24 | $129.0M | $471.1M | ||
| Q2 24 | $123.8M | $509.8M | ||
| Q1 24 | $142.9M | $561.9M |
总债务CLFDPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
股东权益CLFDPACB
| Q4 25 | $249.7M | $5.3M | ||
| Q3 25 | $256.2M | $36.1M | ||
| Q2 25 | $264.5M | $61.5M | ||
| Q1 25 | $265.9M | $91.6M | ||
| Q4 24 | $267.4M | $506.6M | ||
| Q3 24 | $275.8M | $453.1M | ||
| Q2 24 | $274.6M | $492.7M | ||
| Q1 24 | $279.2M | $649.0M |
总资产CLFDPACB
| Q4 25 | $268.1M | $784.1M | ||
| Q3 25 | $306.2M | $803.2M | ||
| Q2 25 | $314.7M | $825.5M | ||
| Q1 25 | $310.9M | $860.8M | ||
| Q4 24 | $303.2M | $1.3B | ||
| Q3 24 | $315.3M | $1.5B | ||
| Q2 24 | $318.1M | $1.5B | ||
| Q1 24 | $315.4M | $1.7B |
负债/权益比CLFDPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $-19.9M |
| 自由现金流率自由现金流/营收 | -7.1% | -44.6% |
| 资本支出强度资本支出/营收 | 2.9% | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-114.1M |
8季度趋势，按日历期对齐
经营现金流CLFDPACB
| Q4 25 | $-1.4M | $-19.1M | ||
| Q3 25 | — | $-18.7M | ||
| Q2 25 | $7.9M | $-29.4M | ||
| Q1 25 | $3.0M | $-44.1M | ||
| Q4 24 | $7.2M | $-30.6M | ||
| Q3 24 | $22.2M | $-45.5M | ||
| Q2 24 | $4.0M | $-54.3M | ||
| Q1 24 | $-5.7M | $-75.7M |
自由现金流CLFDPACB
| Q4 25 | $-2.4M | $-19.9M | ||
| Q3 25 | — | $-18.8M | ||
| Q2 25 | $7.5M | $-29.9M | ||
| Q1 25 | $654.0K | $-45.4M | ||
| Q4 24 | $5.1M | $-32.3M | ||
| Q3 24 | $18.2M | $-46.3M | ||
| Q2 24 | $2.8M | $-55.7M | ||
| Q1 24 | $-7.7M | $-79.6M |
自由现金流率CLFDPACB
| Q4 25 | -7.1% | -44.6% | ||
| Q3 25 | — | -48.9% | ||
| Q2 25 | 15.1% | -75.3% | ||
| Q1 25 | 1.4% | -122.3% | ||
| Q4 24 | 17.1% | -82.3% | ||
| Q3 24 | 323.0% | -115.7% | ||
| Q2 24 | 5.8% | -154.8% | ||
| Q1 24 | -20.8% | -205.0% |
资本支出强度CLFDPACB
| Q4 25 | 2.9% | 1.9% | ||
| Q3 25 | 2.0% | 0.2% | ||
| Q2 25 | 0.8% | 1.4% | ||
| Q1 25 | 5.1% | 3.7% | ||
| Q4 24 | 7.0% | 4.1% | ||
| Q3 24 | 71.4% | 2.0% | ||
| Q2 24 | 2.5% | 4.1% | ||
| Q1 24 | 5.3% | 10.0% |
现金转化率CLFDPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | -12.93× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLFD
暂无分部数据
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
